Clover End Period Cash Flow vs Ev To Free Cash Flow Analysis

CLOV Stock

USD 3.49 0.12 3.56%

Clover Health financial indicator trend analysis is way more than just evaluating Clover Health Investments prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clover Health Investments is a good investment. Please check the relationship between Clover Health End Period Cash Flow and its Ev To Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clover Health Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

End Period Cash Flow vs Ev To Free Cash Flow

End Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clover Health Investments End Period Cash Flow account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have weak relationship.

The correlation between Clover Health's End Period Cash Flow and Ev To Free Cash Flow is 0.31. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of Clover Health Investments, assuming nothing else is changed. The correlation between historical values of Clover Health's End Period Cash Flow and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Clover Health Investments are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Clover Health's End Period Cash Flow and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

End Period Cash Flow

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most indicators from Clover Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clover Health Investments current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clover Health Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Selling General Administrative is likely to climb to about 329.5 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.2 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	557.8M	393.7M	2.0B	2.1B
Cost Of Revenue	1.6B	3.5B	1.8B	1.7B

Total Operating Expenses Cost Of Revenue

Clover Health fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Other Current Assets	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab
Other Current Liab		0.75	-0.2	0.87	-0.78	-0.89	0.43	0.96	-0.42	0.88	0.06	0.57	0.97	-0.78	0.63	-0.85	-0.84	0.7	0.41	0.12	0.95	0.59	0.89	-0.84	0.9	0.71
Total Current Liabilities	0.75		-0.77	0.74	-0.8	-0.38	0.62	0.65	0.24	0.91	-0.43	-0.02	0.71	-0.35	0.8	-0.5	-0.65	0.64	-0.14	-0.39	0.74	0.57	0.76	-0.46	0.75	0.18
Other Liab	-0.2	-0.77		-0.4	0.58	-0.18	-0.52	-0.13	-0.74	-0.55	0.64	0.5	-0.22	-0.07	-0.63	0.12	0.28	-0.36	0.49	0.62	-0.26	-0.11	-0.37	0.02	-0.35	0.28
Net Tangible Assets	0.87	0.74	-0.4		-0.96	-0.69	0.51	0.88	-0.19	0.89	-0.23	0.57	0.93	-0.73	0.82	-0.89	-0.87	0.76	0.16	-0.17	0.86	0.29	0.97	-0.79	0.98	0.5
Retained Earnings	-0.78	-0.8	0.58	-0.96		0.55	-0.44	-0.82	-0.06	-0.85	0.32	-0.41	-0.84	0.68	-0.81	0.8	0.75	-0.64	-0.06	0.26	-0.74	-0.3	-0.95	0.75	-0.94	-0.4
Accounts Payable	-0.89	-0.38	-0.18	-0.69	0.55		-0.16	-0.88	0.72	-0.6	-0.46	-0.73	-0.88	0.88	-0.28	0.88	0.74	-0.54	-0.75	-0.51	-0.83	-0.39	-0.7	0.87	-0.71	-0.93
Other Assets	0.43	0.62	-0.52	0.51	-0.44	-0.16		0.22	0.02	0.75	-0.57	-0.08	0.49	0.09	0.81	-0.32	-0.73	0.89	-0.37	-0.55	0.65	-0.01	0.44	0.02	0.46	-0.14
Net Receivables	0.96	0.65	-0.13	0.88	-0.82	-0.88	0.22		-0.39	0.78	0.15	0.69	0.95	-0.9	0.53	-0.89	-0.76	0.55	0.5	0.21	0.84	0.54	0.93	-0.95	0.93	0.78
Other Current Assets	-0.42	0.24	-0.74	-0.19	-0.06	0.72	0.02	-0.39		-0.08	-0.56	-0.73	-0.41	0.47	0.1	0.45	0.38	-0.27	-0.66	-0.58	-0.44	-0.1	-0.16	0.4	-0.19	-0.66
Total Current Assets	0.88	0.91	-0.55	0.89	-0.85	-0.6	0.75	0.78	-0.08		-0.34	0.28	0.89	-0.5	0.88	-0.72	-0.89	0.86	0.02	-0.28	0.92	0.44	0.88	-0.59	0.89	0.36
Common Stock	0.06	-0.43	0.64	-0.23	0.32	-0.46	-0.57	0.15	-0.56	-0.34		0.29	0.05	-0.46	-0.7	-0.21	0.08	-0.28	0.92	1.0	-0.05	-0.05	-0.18	-0.34	-0.16	0.71
Property Plant Equipment	0.57	-0.02	0.5	0.57	-0.41	-0.73	-0.08	0.69	-0.73	0.28	0.29		0.61	-0.73	0.2	-0.67	-0.47	0.27	0.51	0.33	0.47	0.2	0.59	-0.73	0.6	0.65
Total Assets	0.97	0.71	-0.22	0.93	-0.84	-0.88	0.49	0.95	-0.41	0.89	0.05	0.61		-0.81	0.67	-0.93	-0.92	0.78	0.42	0.1	0.96	0.41	0.93	-0.85	0.94	0.71
Short Long Term Debt Total	-0.78	-0.35	-0.07	-0.73	0.68	0.88	0.09	-0.9	0.47	-0.5	-0.46	-0.73	-0.81		-0.22	0.9	0.61	-0.34	-0.75	-0.51	-0.64	-0.29	-0.75	0.99	-0.77	-0.92
Total Stockholder Equity	0.63	0.8	-0.63	0.82	-0.81	-0.28	0.81	0.53	0.1	0.88	-0.7	0.2	0.67	-0.22		-0.51	-0.74	0.8	-0.38	-0.66	0.72	0.25	0.77	-0.32	0.77	-0.03
Property Plant And Equipment Net	-0.85	-0.5	0.12	-0.89	0.8	0.88	-0.32	-0.89	0.45	-0.72	-0.21	-0.67	-0.93	0.9	-0.51		0.88	-0.7	-0.57	-0.27	-0.84	-0.12	-0.86	0.9	-0.88	-0.8
Net Debt	-0.84	-0.65	0.28	-0.87	0.75	0.74	-0.73	-0.76	0.38	-0.89	0.08	-0.47	-0.92	0.61	-0.74	0.88		-0.95	-0.27	0.03	-0.94	-0.11	-0.82	0.64	-0.85	-0.54
Cash	0.7	0.64	-0.36	0.76	-0.64	-0.54	0.89	0.55	-0.27	0.86	-0.28	0.27	0.78	-0.34	0.8	-0.7	-0.95		0.03	-0.23	0.87	0.01	0.69	-0.38	0.71	0.29
Non Current Assets Total	0.41	-0.14	0.49	0.16	-0.06	-0.75	-0.37	0.5	-0.66	0.02	0.92	0.51	0.42	-0.75	-0.38	-0.57	-0.27	0.03		0.94	0.31	0.07	0.19	-0.66	0.22	0.93
Non Currrent Assets Other	0.12	-0.39	0.62	-0.17	0.26	-0.51	-0.55	0.21	-0.58	-0.28	1.0	0.33	0.1	-0.51	-0.66	-0.27	0.03	-0.23	0.94		0.01	-0.03	-0.12	-0.4	-0.1	0.75
Cash And Short Term Investments	0.95	0.74	-0.26	0.86	-0.74	-0.83	0.65	0.84	-0.44	0.92	-0.05	0.47	0.96	-0.64	0.72	-0.84	-0.94	0.87	0.31	0.01		0.41	0.83	-0.69	0.85	0.61
Good Will	0.59	0.57	-0.11	0.29	-0.3	-0.39	-0.01	0.54	-0.1	0.44	-0.05	0.2	0.41	-0.29	0.25	-0.12	-0.11	0.01	0.07	-0.03	0.41		0.41	-0.39	0.38	0.26
Common Stock Shares Outstanding	0.89	0.76	-0.37	0.97	-0.95	-0.7	0.44	0.93	-0.16	0.88	-0.18	0.59	0.93	-0.75	0.77	-0.86	-0.82	0.69	0.19	-0.12	0.83	0.41		-0.83	1.0	0.52
Non Current Liabilities Total	-0.84	-0.46	0.02	-0.79	0.75	0.87	0.02	-0.95	0.4	-0.59	-0.34	-0.73	-0.85	0.99	-0.32	0.9	0.64	-0.38	-0.66	-0.4	-0.69	-0.39	-0.83		-0.84	-0.86
Other Stockholder Equity	0.9	0.75	-0.35	0.98	-0.94	-0.71	0.46	0.93	-0.19	0.89	-0.16	0.6	0.94	-0.77	0.77	-0.88	-0.85	0.71	0.22	-0.1	0.85	0.38	1.0	-0.84		0.54
Total Liab	0.71	0.18	0.28	0.5	-0.4	-0.93	-0.14	0.78	-0.66	0.36	0.71	0.65	0.71	-0.92	-0.03	-0.8	-0.54	0.29	0.93	0.75	0.61	0.26	0.52	-0.86	0.54

Click cells to compare fundamentals

Clover Health Account Relationship Matchups

Clover Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	118.0K	108.0M	341.4M	397.2M	162.0M	184.9M
Total Current Liabilities	118.0K	33.9M	372.6M	440.7M	261.1M	237.5M
Other Liab	168.0M	155.7M	14.1M	16.2M	14.6M	13.8M
Net Tangible Assets	(492.8M)	(621.3M)	404.2M	327.7M	376.9M	395.7M
Retained Earnings	(17.6K)	(6.8M)	(1.6B)	(2.0B)	(2.2B)	(2.1B)
Accounts Payable	114.8M	30.7M	28.1M	32.4M	94.3M	59.0M
Other Assets	(67.6M)	(589.2M)	950.8M	15.7M	18.1M	17.2M
Net Receivables	44.5M	84.9M	109.4M	147.2M	113.8M	99.3M
Other Current Assets	2.2M	299.7K	17.2M	42.6M	71.5M	36.7M
Total Current Assets	67.6M	28.3M	752.5M	625.0M	428.0M	384.2M
Property Plant Equipment	13.0M	10.0M	7.7M	9.8M	11.2M	9.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clover Stock Analysis

When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC